Antonio V. Escueta, MD

Dr. Eric Williamson joined the UCLA faculty as an associate professor in 2019 and he also serves as director of the West Los Angeles Veterans Administration Hospital's MS Center of Excellence. He earned his medical school degree from the Ohio State University's College of Medicine in 2007. Thereafter, Williamson pursued a residency at the University of Chicago before completing a neuroimmunology fellowship at the University of Southern California and then serving on the faculty at the University of Pennsylvania. While Dr. Williamson�s primary focus is patient care, he is also intimately involved in trials and clinical research efforts to better treat patients with Multiple Sclerosis, serving as an investigator and examiner in a number of research studies. He has particular interest and expertise in conditions such as neuromyelitis optica, transverse myelitis, and infectious central nervous system diseases. Dr. Williamson's research interests have helped to better characterize and examine the potential risks and benefits of neuro-immune therapies. He has and continues to conduct research, lecture on, and write about a number of topics related to Multiple Sclerosis. These topics include infections encountered in demyelinating disease, vaccinations in MS, and the use of monoclonal antibodies and other novel therapies in central nervous system illness.

Mario F. Mendez, MD, PhD, is a behavioral neurologist. His training is in internal medicine, neurology, neurobehavior, and experimental psychology. Dr. Mendez completed an internal medicine residency at USC-LAC Medical Center and briefly practiced medicine before returning to do a neurology residency at UCLA. Under the mentorship of D. Frank Benson, Dr. Mendez went on to do a neurobehavior fellowship. The development of research interests in brain-behavior disorders resulted in completing of the qualifications for a PhD in experimental psychology. Dr. Mendez is the Director of Neurobehavior at the VA Greater Los Angeles and Professor of Neurology and Psychiatry at UCLA. He directs the Focal-type Dementia Clinic and Program. His area of investigation is the clinical aspects of frontotemporal dementia, progressive aphasia, posterior cortical atrophy, and other focal cortical degenerative conditions.

Dr. Jean-Philippe Langevin specializes in surgical treatment of movement disorders, epilepsy, and psychiatric conditions. He has extensive experience in the use of neuromodulation to treat conditions such as movement disorders, epilepsy, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD). His research is focused on understanding neurocircuitry dysfunctions in psychiatric conditions.